|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1001 G STREET, NW |
Address2 | SUITE 900 EAST |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 31680-2512
|
||||||||
|
6. House ID# 311100190
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Kimberley Fritts, CEO |
Date | 01/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Drug Importation
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions)
S. 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011 (FDA Appropriations, Drug Importation)
S. 3636 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011 (PTO Provisions, Drug Importation
S. 3607 Department of Homeland Security Appropriations Act, 2011 (Drug Importation)
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011
H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011 PL 111-322
H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes PL 111-317
H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes, PL 111-290
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Thomas |
Sparkman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S. 515 Patent Reform Act of 2009
S. 610 Patent Reform Act of 2009
H.R. 1260 Patent Reform Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Thomas |
Sparkman |
|
|
|
Daniele |
Baierlein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R. 1402 Catalyst to Better Diabetes Care Act of 2009
S. 1473 Catalyst to Better Diabetes Care Act of 2009
H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2010
S. 844 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009
H.R. 2590 Preventing Diabetes in Medicare Act of 2009
Obesity/Diabetes Issues
P.L. 111-148 Patient Protection and Affordable Care Act implementation
P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation
H.R. 6012 To direct the Secretary of Health and Human Services to review utilization of diabetes screening benefits and make recommendations on outreach programs with respect to such benefits, and for other purposes
H.R. 5354, Gestational Diabetes Act of 2010
H.R. 6012, Diabetes Screening bill
S. 844, Elimination Disparities in Diabetes Prevention Access and Care Act of 2009
S. 3397, Secure and Responsible Drug Disposal Act of 2010, PL 111-273
H.R. 6331, Generating Antibiotic Incentives Now Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Thomas |
Sparkman |
|
|
|
Daniele |
Baierlein |
|
|
|
Donnice |
Turner |
|
|
|
Thomas |
Borck |
|
|
|
Anne Marie |
Polak |
|
Legislative Correspondent, Rep. Mike Ferguson |
|
Anne Marie |
Polak |
|
Asst. Scheduler / Scheduler, Rep. Dick Armey |
|
Anne Marie |
Polak |
|
Briefing Book Coordinator / Sec'y of Labor, DOL |
|
Randall |
Gerard |
|
Staff Asst., Sen. Cmrce, Science & Transport Cmte. |
|
Randall |
Gerard |
|
Intern, Sen. John McCain |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Comparative Effectiveness
Medicare Issues
P.L. 111-148 Patient Protection and Affordable Care Act implementation
P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation
S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals
H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions)
H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision)
H.R. 6012 To direct the Secretary of Health and Human Services to review utilization of diabetes screening benefits and make recommendations on outreach programs with respect to such benefits, and for other purposes
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions)
H.R. 4994, Medicare and Medicaid Extenders Act of 2010 , P.L. 111-309
H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
Sparkman |
|
|
|
Sharon |
Cohen |
|
|
|
Daniele |
Baierlein |
|
|
|
Donnice |
Turner |
|
|
|
Thomas |
Borck |
|
|
|
Anne Marie |
Polak |
|
Legislative Correspondent, Rep. Mike Ferguson |
|
Anne Marie |
Polak |
|
Asst. Scheduler / Scheduler, Rep. Dick Armey |
|
Anne Marie |
Polak |
|
Briefing Book Coordinator / Sec'y of Labor, DOL |
|
Randall |
Gerard |
|
Staff Asst., Sen. Cmrce, Science & Transport Cmte. |
|
Randall |
Gerard |
|
Intern, Sen. John McCain |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Drug Importation, Biosimilars
P.L. 111-148 Patient Protection and Affordable Care Act
P.L. 111-152 Health Care and Education Reconciliation Act of 2010
S. 3607 Department of Homeland Security Appropriations Act, 2011 (Drug Importation)
S. 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011 (FDA Appropriations, Drug Importation)
S. 3636 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011 (PTO Provisions, Drug Importation)
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions)
S. 3397 Secure and Responsible Drug Disposal Act of 2010
H.R. 1359 Secure and Responsible Drug Disposal Act of 2009
H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 201; P.L. 111-322
H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; P.L. 111-317
H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; P.L. 111-290
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Donnice |
Turner |
|
|
|
Thomas |
Sparkman |
|
|
|
Anne Marie |
Polak |
|
Legislative Correspondent, Rep Mike Ferguson |
|
Anne Marie |
Polak |
|
Asst. Scheduler / Scheduler, Rep. Dick Armey |
|
Anne Marie |
Polak |
|
Briefing Book Coordinator / Sec'y of Labor, DOL |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
P.L. 111-148 Patient Protection and Affordable Care Act implementation
P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation
H.R. 6012 To direct the Secretary of Health and Human Services to review utilization of diabetes screening benefits and make recommendations on outreach programs with respect to such benefits, and for other purposes
H.R. 1995 Diabetes in Minority Populations Evaluation Act of 2010
H.R. 5354 Gestational Diabetes Act of 2010
S. 3397 Secure and Responsible Drug Disposal Act of 2010
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Diabetes Related Provisions)
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions)
H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision)
H.R. 1359 Secure and Responsible Drug Disposal Act of 2009
H.R. 5354, Gestational Diabetes Act of 2010
H.R. 6012, Diabetes Screening bill
S. 844, Elimination Disparities in Diabetes Prevention Access and Care Act of 2009
S. 3397, Secure and Responsible Drug Disposal Act of 2010, PL 111-273
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Cohen |
|
|
|
Thomas |
Sparkman |
|
|
|
Daniele |
Baierlein |
|
|
|
Donnice |
Turner |
|
|
|
Thomas |
Borck |
|
|
|
Anne Marie |
Polak |
|
Legislative Correspondent, Rep. Mike Ferguson |
|
Anne Marie |
Polak |
|
Asst. Scheduler / Scheduler, Rep. Dick Armey |
|
Anne Marie |
Polak |
|
Briefing Book Coordinator / Sec'y of Labor, DOL |
|
Randall |
Gerard |
|
Staff Asst., Sen. Cmrce, Science, & Transport Cmte. |
|
Randall |
Gerard |
|
Intern, Sen. John McCain |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
Novo Nordisk A/S |
|
|
0.00 | 0 % |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |